K Walker

Summary

Affiliation: Novartis Institutes for BioMedical Research

Publications

  1. ncbi Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain
    K Walker
    Nervous System Research, Novartis Pharma AG, CH 4002, Basle, Switzerland
    Neuropharmacology 40:1-9. 2001
  2. ncbi mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia
    K Walker
    Novartis Pharma AG, Nervous System Research, CH 4002, Basle, Switzerland
    Neuropharmacology 40:10-9. 2001

Detail Information

Publications2

  1. ncbi Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain
    K Walker
    Nervous System Research, Novartis Pharma AG, CH 4002, Basle, Switzerland
    Neuropharmacology 40:1-9. 2001
    ..In contrast to its effects in models of inflammatory pain, MPEP did not produce significant reversal of mechanical hyperalgesia in a rat model of neuropathic pain...
  2. ncbi mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia
    K Walker
    Novartis Pharma AG, Nervous System Research, CH 4002, Basle, Switzerland
    Neuropharmacology 40:10-9. 2001
    ..These results suggest that mGlu5 receptors expressed on the peripheral terminals of sensory neurones are involved in nociceptive processes and contribute to the hyperalgesia associated with inflammation...